|
|
Effects of meibomian gland massage combined with Croma corneal protector on dry eyes after phacoemulsification for cataract#br# |
ZHU Min CHEN Yubing ZENG Jun AO Sichun YU Dan |
Department of Ophthalmology, Foshan First People’s Hospital, Guangdong Province, Foshan 528000, China |
|
|
Abstract Objective To investigate the effects of meibomian gland massage combined with Croma corneal protector in the treatment of dry eye after phacoemulsification. Methods According to the random number table method, 82 patients with dry eye after phacoemulsification in Foshan First People’s Hospital from October 2018 to April 2020 were divided into study group and control group, with 41 cases in each group. The control group was treated with meibomian gland massage, and the study group was treated with Croma corneal protector in addition to the control group, all were treated for two weeks. The clinical efficacy, dry eye before and after treatment, disease remission and incidence of adverse events were compared between the two groups. Results After treatment, the total effective rate of study group was higher than that of control group (P < 0.05); the objective scattering index (OSI), corneal fluorescein staining (CFL), ocular surface signs, and sensory symptom scores of the two groups were lower than those before treatment, and the OSI, CFL, ocular surface signs and sensory symptom scores of study group were lower than those of control group (P < 0.05); the Schirmer I test (SIt) value in two groups was higher than that before treatment, and the SIt value in study group was higher than that in control group (P < 0.05); there was no significant difference in the incidence of adverse events between two groups (P > 0.05). Conclusion Meibomian gland massage and Croma corneal protector can effectively prevent dry eye symptoms after phacoemulsification with definite curative effect and high safety.
|
|
|
|
|
[1] 张键,唐蕾,李环宇,等.超声乳化白内障手术两种不同切口对术后干眼的影响分析[J].医学理论与实践,2020, 33(2):260-262.
[2] 涂相红.角膜保护剂对白内障患者外科治疗效果影响的分析[J].贵州医药,2017,41(1):63-65.
[3] 马春,王霞,何丽华.睑板腺按摩护理在年龄相关性白内障术后干眼患者中的应用[J].齐鲁护理杂志,2019,25(10):56-58.
[4] 姚帮桃,赵孝贵,董照阳.白内障超声乳化术前睑板腺按摩对合并睑板腺功能障碍患者术后眼表的影响[J].国际眼科杂志,2016,16(6):1171-1173.
[5] 俞晓宇,王丹丹,常平骏,等.角膜保护剂对白内障术后干眼的影响[J].中华眼视光学与视觉科学杂志,2017,19(4):236-242.
[6] 中华医学会眼科学分会白内障及人工晶状体学组.我国白内障摘除手术后感染性眼内炎防治专家共识(2017年)[J].中华眼科杂志,2017,53(11):810-813.
[7] Nelson JD,Shimazaki J,Benitez-del-Castillo JM,et al. The international workshop on meibomian gland dysfunction:report of the definition and classification subcommittee [J]. Invest Ophthalmol Vis Sci,2011,52(4):1930-1937.
[8] 余孟婷,吴文捷,吴鑫娜,等.白内障超声乳化手术前后眼表的变化[J].国际眼科杂志,2019,19(11):1962-1966.
[9] 王敏,张丽君,孙玉平.综合护理干预对减少白内障超声乳化术后干眼症的效果观察及价值分析[J].当代医学,2019,25(6):78-80.
[10] 杨晓英,魏欢,陈丽,等.徒手睑板腺按摩在睑板腺功能障碍型(MGD)干眼治疗中的应用[J].眼科学,2017,6(2):55-60.
[11] 黄丹菊,李燕娜.睑板腺按摩对睑板腺功能障碍性干眼的干预价值[J].中医眼耳鼻喉杂志,2021,11(1):25-26,29.
[12] 张春妍,董微丽,郭立涛,等.角膜保护剂对2型糖尿病患者白内障超声乳化术后眼表的影响[J].国际眼科杂志,2019,19(4):555-558.
[13] 周凌霄,邵蕾,周金琼,等.角膜保护剂在玻璃体视网膜手术中的应用价值观察[J].临床眼科杂志,2017,25(5):447-449.
[14] 王重任.角膜保护剂应用于2型糖尿病患者白内障超声乳化术后效果及对眼表的影响[J].医学理论与实践,2020,33(22):3776-3777.
[15] 谢慧,周丽云.白内障合并睑板腺功能障碍患者行超声乳化术前睑板腺按摩对术后眼表的影响探讨[J].中国现代医生,2019,57(30):63-66.
[16] 王鹏月.睑板腺功能障碍性干眼患者实施睑板腺按摩护理的效果评价[J].中西医结合心血管病电子杂志,2020, 8(32):129,132.
[17] 朱萍,吴仲新,封艳,等.角膜保护剂对白内障患者手术治疗效果的保护作用[J].中国乡村医药,2019,26(4):10-11.
[18] 庞蒙.白内障合并不同类型散光患者进行白内障超声乳化吸除术联合人工晶体植入术后的屈光状态对比[J].当代医药论丛,2021,19(2):71-72.
[19] 王惠红.白内障超声乳化联合人工晶体植入术的疗效观察[J].健康必读,2021(7):277.
[20] 黄超,赵永,王梅,等.超声乳化联合房角分离术与小梁切除术治疗急性闭角型青光眼合并白内障[J].国际眼科杂志,2019,19(3):418-421.
[21] 梁景黎,邢秀丽,杨晓彤,等.2.2 mm和3.0 mm透明角膜切口超声乳化白内障吸除术后全角膜及角膜前后表面术源性散光的比较分析[J].中华眼科杂志,2019, 55(7):495-501.
[22] 张雪,闫欢欢,艾华,等.白内障超声乳化联合人工晶状体植入术治疗原发性闭角型青光眼合并白内障的效果观察[J].实用临床医药杂志,2019,23(14):86-89.
[23] 戴兵,颜超.不同手术方式治疗青光眼合并白内障临床疗效比较[J].中华实验眼科杂志,2017,35(5):467-468.
[24] 姚克.我国白内障研究发展方向及面临的问题[J].中华眼科杂志,2015,51(4):241-244.
[25] 赵家良.提高白内障手术率是我国防盲治盲的当务之急[J].中华医学杂志,2013,93(47):3729-3730.
[26] 曹蓓.超声乳化白内障摘除术与小切口非超声乳化治疗高龄白内障的效果比较[J].当代医学,2021,27(34):105-107.
[27] 苏文华,李珣旖,刘越,等.白内障超声乳化摘除术中灌注液瓶高度对角膜内皮的影响[J].当代医学,2020,26(14):169-171.
[28] 陈迪,张顺华,卞爱玲,等.适应医院临床工作的白内障手术Wet lab培训模式的建立与实践[J].中国医药导报,2021,18(19):92-94,101. |
|
|
|